A Phase I-II Intensive-Dose Ifosfamide, Carboplatin and Taxotere (IC-T) Combination Chemotherapy Followed by Autologous Stem Cell Rescue for Patients With Refractory Malignancies

Trial Profile

A Phase I-II Intensive-Dose Ifosfamide, Carboplatin and Taxotere (IC-T) Combination Chemotherapy Followed by Autologous Stem Cell Rescue for Patients With Refractory Malignancies

Completed
Phase of Trial: Phase I/II

Latest Information Update: 10 Sep 2005

At a glance

  • Drugs Docetaxel (Primary) ; Carboplatin; Ifosfamide
  • Indications Advanced breast cancer; Hodgkin's disease; Non-Hodgkin's lymphoma; Ovarian cancer; Testicular cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top